Table 4.
Variable | Fibrosis stage 0–2 (n=174) | Fibrosis stage 3–4 (n=106) | P value | NAS 1–4 (n=127) | NAS 5–8 (n=153) | P value |
---|---|---|---|---|---|---|
Insulin, μU/mL | 11.7 (7.2–16.3) | 17.1 (12.6–26.4) | <0.01 | 11.0 (6.9–16) | 15.4 (11.6–23.9) | <0.01 |
HOMA-IR | 2.96 (1.88–4.76) | 5.30 (3.46–7.64) | <0.01 | 2.83 (1.68–4.51) | 4.71 (2.94–7.07) | <0.01 |
Values are presented as median (interquartile range). To evaluate between-group differences, the Mann-Whitney U test was used for continuous variables. P<0.05 was considered significant.
HOMA-IR, homeostasis model assessment of insulin resistance; NAS, NAFLD activity score.